Introduction to SGLT2 Inhibition

February 6, 2014 12:10 pm

The management of Type 2 Diabetes (T2D) is complex and challenging.

Sodium glucose cotransporter 2 (SGLT2) inhibition offers a different mode of action from other oral glucose lowering treatments.

Find out more about SGLT2 inhibition and its potential impact on T2D management.

Category: News
About The Author
-
Next

Medication adherence in Malaysian patients with T2D – Video abstract 81612

Related Videos

Sodium-Glucose-Transporter-2-Inhibition-An-Important-Advancement-for-Patients-with-T2D-and-CKD

Sodium-Glucose Transporter-2 Inhibition: An Important Advancement for Patients with T2D and CKD

Diabetes-Epigenome-Atlas-DGA-and-T2D-Knowledge-Portal-September-26-2019-Webinar

Diabetes Epigenome Atlas (DGA) and T2D Knowledge Portal: September 26, 2019 Webinar

T2D-and-CV-Risk-Reduction-Future-Management

T2D and CV Risk Reduction: Future Management

Type-2-diabetes-remission-Reducing-excess-fat-in-the-liver-might-be-the-keyteaser

Type 2 diabetes remission: Reducing excess fat in the liver might be the keyteaser

Unleashing-the-Truth-Approaching-T2D-Treatment-as-a-Team-Sport

Unleashing the Truth: Approaching T2D Treatment as a Team Sport

Diabetes-debunked-Fact-vs.-fiction-on-ways-to-prevent-manage-and-reverse-the-disease

Diabetes debunked: Fact vs. fiction on ways to prevent, manage, and reverse the disease